Guardant Health, Inc.·4

May 28, 6:32 PM ET

Saia John G. 4

Research Summary

AI-generated summary

Updated

Guardant Health (GH) Chief Legal Officer John Saia Sells 10,000 Shares

What Happened
John G. Saia, Chief Legal Officer of Guardant Health (GH), sold a total of 10,000 company shares in open-market transactions on May 27, 2026, generating approximately $1,250,836 in proceeds. The main block was 9,994 shares reported at a weighted average price of $125.08 (proceeds $1,250,080); an additional 6 shares were sold at $126.08 (proceeds $756). These were dispositions (sales), not purchases or option exercises.

Key Details

  • Transaction date: 2026-05-27 (Form 4 filed 2026-05-28). Filing appears timely (filed the next day).
  • Transaction type/code: Open-market sales (S).
  • Shares sold: 9,994 shares at a weighted average of $125.08; 6 shares at $126.08 — total 10,000 shares for ~$1,250,836.
  • Price range note (footnote F1): the 9,994-share block was sold in multiple transactions at prices between $125.00 and $125.44; the filer offered to provide a full breakdown to the SEC or shareholders on request.
  • Shares owned after transaction: Not specified in the provided excerpt — check the full Form 4 for post-transaction holdings.
  • No indication in the provided data of a 10b5-1 plan, gift, tax-withholding sale, or other special conditions; filing text should be checked for any additional footnotes.

Context

  • This was a sale (a routine disposition), which does not by itself indicate company prospects. Purchases are typically a stronger signal of insider confidence; sales can reflect diversification, tax planning, or other personal reasons.
  • For full context, retail investors should review the complete Form 4 for post-sale holdings and any additional footnotes or instructions (e.g., 10b5-1 plan language) and monitor other insider transactions and company news.